Muscular Dystrophy (MD) refers to a group of genetic disorders characterized by progressive muscle weakness and degeneration. This condition is caused by mutations in genes responsible for the structure and function of muscle cells. 

 

There are several types of muscular dystrophy, each with specific patterns of muscle weakness, age of onset, and severity. Some common types include Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy.

 

Symptoms of muscular dystrophy typically manifest during childhood, although they can appear later in life. These symptoms may include difficulty walking, frequent falls, muscle weakness and wasting, progressive loss of mobility, respiratory difficulties, and heart problems.

 

Treatment for muscular dystrophy focuses on managing symptoms, slowing disease progression, and improving quality of life. This may involve physiotherapy to maintain muscle function and mobility, orthopedic interventions to address joint contractures and scoliosis, respiratory support to assist breathing, and medications to manage symptoms such as pain and muscle stiffness.

 

While there is currently no cure for muscular dystrophy, ongoing research and advances in medical care have led to improved outcomes and quality of life for individuals living with this condition. Early diagnosis and multidisciplinary care are essential for optimizing treatment outcomes and supporting individuals affected by muscular dystrophy.

 

Pimpama neurological physiotherapists can play a significant role in helping individuals with Muscular Dystrophy (MD) manage their symptoms and maintain functional abilities. Here are some ways they can assist: